Skip to main content

Experimental weight-loss drug from a small biotech could outdo Ozempic

By The Washington Post  
   February 27, 2024

Viking Therapeutics posted results of an experimental drug that showed even better weight loss than the current market-leading drugs, a sign that the dominance of Ozempic and Mounjaro is far from assured.

Full story

Get the latest on healthcare leadership in your inbox.